Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,836 | 21 | 72.2% |
| Education | $708.57 | 5 | 27.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $716.84 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $555.46 | 7 | $0 (2024) |
| Amgen Inc. | $490.20 | 7 | $0 (2024) |
| Boston Scientific Corporation | $267.17 | 2 | $0 (2023) |
| Astellas Pharma US Inc | $205.56 | 3 | $0 (2021) |
| Impulse Dynamics (USA) Inc. | $120.70 | 1 | $0 (2023) |
| Medtronic, Inc. | $110.00 | 1 | $0 (2024) |
| AtriCure, Inc. | $78.44 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $398.41 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($268.20) |
| 2023 | $1,004 | 10 | Amgen Inc. ($288.94) |
| 2022 | $512.53 | 5 | Abbott Laboratories ($253.04) |
| 2021 | $323.97 | 4 | Astellas Pharma US Inc ($205.56) |
| 2020 | $305.14 | 2 | Abbott Laboratories ($305.14) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: Renal Denervation System | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: DIABETES | ||||||
| 05/15/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 12/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: DIABETES | ||||||
| 11/09/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $148.76 | General |
| Category: General - Tachy_CRM | ||||||
| 10/18/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiology | ||||||
| 10/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 09/28/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardiology | ||||||
| 09/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 09/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: DIABETES | ||||||
| 05/05/2023 | Abbott Laboratories | OPTIS (Device) | Food and Beverage | In-kind items and services | $158.66 | General |
| Category: Vascular | ||||||
| 04/27/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $120.70 | General |
| Category: Cardiovascular Device | ||||||
| 02/16/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $123.92 | General |
| Category: Cardiology | ||||||
| 11/10/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 10/20/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Education | In-kind items and services | $253.04 | General |
| Category: Heart Failure | ||||||
| 06/16/2022 | AtriCure, Inc. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $78.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/10/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: Cardiology | ||||||
| 01/26/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Cardiology | ||||||
| 09/22/2021 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Education | In-kind items and services | $118.41 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/16/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $81.99 | General |
| 09/08/2021 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $23.58 | General |
| 03/11/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 02/24/2020 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 938 | 1,044 | $305,965 | $69,527 |
| 2022 | 11 | 307 | 329 | $100,811 | $24,427 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 93 | 93 | $82,398 | $16,287 | 19.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 268 | 271 | $63,143 | $15,291 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 88 | $36,168 | $9,884 | 27.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 36 | $27,756 | $5,583 | 20.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 41 | $16,154 | $4,419 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 28 | $14,616 | $3,043 | 20.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 26 | 27 | $12,123 | $2,493 | 20.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $9,564 | $2,435 | 25.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 33 | $9,009 | $2,365 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $9,525 | $2,000 | 21.0% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 68 | 71 | $6,816 | $1,550 | 22.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 19 | 19 | $5,567 | $1,226 | 22.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 60 | 84 | $5,628 | $1,046 | 18.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 41 | 54 | $685.00 | $453.60 | 66.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 23 | 23 | $1,909 | $391.68 | 20.5% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 24 | 24 | $1,632 | $370.56 | 22.7% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 43 | 43 | $1,204 | $274.77 | 22.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 23 | 23 | $1,242 | $260.41 | 21.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 58 | 59 | $826.00 | $154.58 | 18.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 29 | 29 | $25,041 | $5,438 | 21.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 39 | 40 | $20,880 | $5,066 | 24.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 78 | 78 | $18,174 | $4,845 | 26.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $11,565 | $2,763 | 23.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 39 | $10,647 | $2,575 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 17 | $4,709 | $1,470 | 31.2% |
About Dr. Nathan Tehrani, MD
Dr. Nathan Tehrani, MD is a Cardiovascular Disease healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2015. The National Provider Identifier (NPI) number assigned to this provider is 1295122018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathan Tehrani, MD has received a total of $2,544 in payments from pharmaceutical and medical device companies, with $398.41 received in 2024. These payments were reported across 26 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,836).
As a Medicare-enrolled provider, Tehrani has provided services to 1,245 Medicare beneficiaries, totaling 1,373 services with total Medicare billing of $93,955. Data is available for 2 years (2022–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Flushing, NY
- Active Since 04/20/2015
- Last Updated 12/20/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1295122018
Products in Payments
- JARDIANCE (Drug) $555.46
- Repatha (Biological) $469.99
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $253.04
- OPTIS (Device) $158.66
- Ensite Cardiac Mapping System (Device) $155.14
- HeartMate 3 Left Ventricular Dev (Device) $150.00
- OPTIMIZER (Device) $120.70
- GENERAL PAIN MANAGEMENT (Device) $118.41
- SYMPLICITY G3 (Device) $110.00
- ATRICLIP LAA EXCLUSION SYSTEM (Device) $78.44
- UPLIZNA (Biological) $20.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Flushing
Madar Abed, Md, MD
Cardiovascular Disease — Payments: $98,164
Dr. Joseph Ma, Md, MD
Cardiovascular Disease — Payments: $18,815
Dr. Jiong-Ming Hu, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $16,826
Dr. Wai Leung, M.d, M.D
Cardiovascular Disease — Payments: $15,212
Dr. Thomas Chen, M.d, M.D
Cardiovascular Disease — Payments: $12,856
Chong Park, Md, MD
Cardiovascular Disease — Payments: $12,111